BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 3, 2015
View Archived Issues
Initiation of clinical trial of TLR7 agonist GS-9620 in HIV-positive patients on ART
Read More
ISA Pharmaceuticals begins first phase I/II trial of Amplivant conjugates
Read More
Biogen Idec and Sobi report topline data from phase III Alprolix pediatric trial
Read More
Johnson & Johnson Health and Wellness Solutions formed to encourage well-being and quality of life
Read More
Cipher Pharmaceuticals acquires three dermatology products from Astion Pharma
Read More
New N-type calcium channel blockers disclosed by Janssen
Read More
Investigators at Duke University divulge new LpxC inhibitors
Read More
Pacira receives FDA complete response letter for Exparel sNDA
Read More
Cadila Healthcare patents new JAK inhibitors
Read More
Boehringer Ingelheim discloses new ENaC blockers
Read More
Russian and U.S. investigators present new adenosine A2A receptor antagonists
Read More
Phase II data lead to phase III initiation for HIV candidate BMS-663068
Read More
Abraxane approved by European Commission for first-line treatment of NSCLC
Read More
FDA accepts Alexion's BLA for asfotase alfa in hypophosphatasia for priority review
Read More
EMA committee recommends approval of Avastin plus chemotherapy for advanced cervical cancer
Read More
European Commission approves Xydalba for ABSSSI
Read More
Tenofovir alafenamide fumarate subject of several presentations at CROI
Read More
Shire submits NDA for lifitegrast for dry eye
Read More
Taiho seeks European approval for TAS-102 for metastatic colorectal cancer
Read More
FDA accepts for filing Xadago NDA
Read More
New clinical trial evaluates ZMapp for Ebola virus
Read More
Envelope-specific monoclonal antibodies offer a novel approach for the treatment of HIV infection
Read More
Torii gains rights from Japan Tobacco to market Gilead tenofovir alafenamide combinations in Japan
Read More
Boehringer Ingelheim files for approval of dabigatran antidote idarucizumab
Read More
FDA accepts sBLA for Yervoy in stage III melanoma
Read More
CHMP recommends approval of Humira for severe chronic plaque psoriasis in children
Read More